Ownership history in Euclidean Capital LLC · 21 quarters on record
This page tracks every 13F SEC filing in which Euclidean Capital LLC reported a position in ORIC PHARMACEUTICALS INC (ORIC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 989,410 | — | 0% | 2.19% | $8.1M | $8.18 |
| 2025 Q3 | UNCHANGED | 989,410 | — | 0% | 4.99% | $11.9M | $12.00 |
| 2025 Q2 | UNCHANGED | 989,410 | — | 0% | 3.28% | $10.0M | $10.15 |
| 2025 Q1 | UNCHANGED | 989,410 | — | 0% | 2.07% | $5.52B | $5.58 |
| 2024 Q4 | UNCHANGED | 989,410 | — | 0% | 1.08% | $8.0M | $8.07 |
| 2024 Q3 | UNCHANGED | 989,410 | — | 0% | 1.12% | $10.1M | $10.25 |
| 2024 Q2 | UNCHANGED | 989,410 | — | 0% | 0.88% | $7.0M | $7.07 |
| 2024 Q1 | UNCHANGED | 989,410 | — | 0% | 1.74% | $13.6M | $13.75 |
| 2023 Q4 | UNCHANGED | 989,410 | — | 0% | 1.02% | $9.1M | $9.20 |
| 2023 Q3 | ADDED | 989,410 | +241,860 | +32.4% | 1.31% | $6.0M | $6.05 |
As of 2025 Q4 — sorted by position size